373 related articles for article (PubMed ID: 36293446)
1. Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity-When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood.
Griesler B; Schuelke C; Uhlig C; Gadasheva Y; Grossmann C
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293446
[TBL] [Abstract][Full Text] [Related]
2. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Nongenomic effects via the mineralocorticoid receptor.
Ruhs S; Nolze A; Hübschmann R; Grossmann C
J Endocrinol; 2017 Jul; 234(1):T107-T124. PubMed ID: 28348113
[TBL] [Abstract][Full Text] [Related]
3. Rapid mineralocorticoid receptor trafficking.
Gekle M; Bretschneider M; Meinel S; Ruhs S; Grossmann C
Steroids; 2014 Mar; 81():103-8. PubMed ID: 24252381
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid receptor actions in cardiovascular development and disease.
Young MJ; Clyne CD
Essays Biochem; 2021 Dec; 65(6):901-911. PubMed ID: 34414409
[TBL] [Abstract][Full Text] [Related]
5. New aspects of rapid aldosterone signaling.
Grossmann C; Gekle M
Mol Cell Endocrinol; 2009 Sep; 308(1-2):53-62. PubMed ID: 19549592
[TBL] [Abstract][Full Text] [Related]
6. Structure-function relationships of the aldosterone receptor.
Fuller PJ; Young MJ; Yang J; Cole TJ
Vitam Horm; 2023; 123():285-312. PubMed ID: 37717989
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators.
Meinel S; Gekle M; Grossmann C
Steroids; 2014 Dec; 91():3-10. PubMed ID: 24928729
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoids in the heart and vasculature: new insights for old hormones.
Lother A; Moser M; Bode C; Feldman RD; Hein L
Annu Rev Pharmacol Toxicol; 2015; 55():289-312. PubMed ID: 25251996
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists.
Ronconi V; Turchi F; Appolloni G; di Tizio V; Boscaro M; Giacchetti G
Curr Vasc Pharmacol; 2012 Mar; 10(2):238-46. PubMed ID: 22022770
[TBL] [Abstract][Full Text] [Related]
10. Modulation of transcriptional mineralocorticoid receptor activity by casein kinase 1.
Ruhs S; Griesler B; Huebschmann R; Stroedecke K; Straetz N; Ihling C; Sinz A; Masch A; Schutkowski M; Gekle M; Grossmann C
FASEB J; 2022 Jan; 36(1):e22059. PubMed ID: 34847273
[TBL] [Abstract][Full Text] [Related]
11. New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.
Davel AP; Jaffe IZ; Tostes RC; Jaisser F; Belin de Chantemèle EJ
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H989-H999. PubMed ID: 29957022
[TBL] [Abstract][Full Text] [Related]
12. Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease.
Parker BM; Wertz SL; Pollard CM; Desimine VL; Maning J; McCrink KA; Lymperopoulos A
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486399
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the Mineralocorticoid Receptor With RACK1 and Its Role in Aldosterone Signaling.
Kuppusamy M; Gomez-Sanchez EP; Beloate LN; Plonczynski M; Naray-Fejes-Toth A; Fejes-Toth G; Gomez-Sanchez CE
Endocrinology; 2017 Jul; 158(7):2367-2375. PubMed ID: 28472300
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Mineralocorticoid Receptor Signaling.
Fuller PJ; Yang J; Young MJ
Vitam Horm; 2019; 109():37-68. PubMed ID: 30678864
[TBL] [Abstract][Full Text] [Related]
15. Modulation of transcriptional mineralocorticoid receptor activity by casein kinase 2.
Ruhs S; Strätz N; Quarch K; Masch A; Schutkowski M; Gekle M; Grossmann C
Sci Rep; 2017 Nov; 7(1):15340. PubMed ID: 29127314
[TBL] [Abstract][Full Text] [Related]
16. Nongenotropic aldosterone effects and the EGFR: interaction and biological relevance.
Grossmann C; Gekle M
Steroids; 2008 Oct; 73(9-10):973-8. PubMed ID: 18249428
[TBL] [Abstract][Full Text] [Related]
17. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions.
Grossmann C; Benesic A; Krug AW; Freudinger R; Mildenberger S; Gassner B; Gekle M
Mol Endocrinol; 2005 Jul; 19(7):1697-710. PubMed ID: 15761031
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease.
Gorini S; Marzolla V; Mammi C; Armani A; Caprio M
Biomolecules; 2018 Sep; 8(3):. PubMed ID: 30231508
[TBL] [Abstract][Full Text] [Related]
19. Structural and molecular determinants of mineralocorticoid receptor signalling.
Grossmann C; Almeida-Prieto B; Nolze A; Alvarez de la Rosa D
Br J Pharmacol; 2022 Jul; 179(13):3103-3118. PubMed ID: 34811739
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of ligand specificity of the mineralocorticoid receptor.
Fuller PJ; Yao Y; Yang J; Young MJ
J Endocrinol; 2012 Apr; 213(1):15-24. PubMed ID: 22159507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
